(Q32090687)

6 July 2017

Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study (English)

1 reference

6 July 2017

1 reference

1 reference

1 reference

1 reference

Tsubota A

1

1 reference

6 July 2017

Arase Y

2

1 reference

6 July 2017

Saitoh S

3

1 reference

6 July 2017

Kobayashi M

4

1 reference

6 July 2017

Suzuki Y

5

1 reference

6 July 2017

Suzuki F

6

1 reference

6 July 2017

Chayama K

7

1 reference

6 July 2017

Murashima N

8

1 reference

6 July 2017

Ikeda K

9

1 reference

6 July 2017

Kobayashi M

10

1 reference

6 July 2017

Kumada H

11

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

The American Journal of Gastroenterology

6 July 2017

1 reference

6 July 2017

96

1 reference

6 July 2017

2

1 reference

6 July 2017

557-562

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

6 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

A preliminary trial of lamivudine for chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03559.X

10.1111/J.1572-0241.2001.03559.X

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference